Related Experiment Video
Updated: May 23, 2026
08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
The aging patient with hemophilia
1Puget Sound Blood Center, University of Washington School of Medicine, Seattle, Washington 98104, USA. barbarak@psbc.org
American Journal of Hematology
|March 21, 2012
Summary
Aging individuals with hemophilia face unique health challenges. This review addresses managing hemophilia alongside common age-related conditions like cardiovascular and renal disease.
Area of Science:
- Hematology
- Geriatrics
- Internal Medicine
Background:
- Modern hemophilia treatments offer normal life expectancy.
- Aging hemophilia patients encounter challenges managing their condition and age-related comorbidities.
- Limited data exists on comorbidity prevalence and management in this population.
Purpose of the Study:
- To review challenges in managing hemophilia in aging patients.
- To discuss complications of cardiovascular, musculoskeletal, hepatic, and renal diseases in this demographic.
- To summarize current research and propose management strategies.
Main Methods:
- Literature review of available research on hemophilia comorbidities.
- Synthesis of data on prevalence and management of age-related diseases in hemophilia.
- Discussion of potential therapeutic and management approaches.
Main Results:
- Aging hemophilia patients experience similar age-related health issues as the general population.
- Specific focus on cardiovascular, musculoskeletal, hepatic, and renal complications is warranted.
- Data on comorbidity management in hemophilia requires further investigation.
Conclusions:
- Comprehensive management strategies are needed for aging hemophilia patients.
- Addressing both hemophilia and common comorbidities is crucial for quality of life.
- Further research is essential to guide clinical practice for this growing population.
Related Concept Videos
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...